• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Anti-VEGF Therapy or Vitrectomy Surgery for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy.

作者信息

Tan Gavin Siew-Wei, Chakravarthy Usha, Wong Tien Yin

机构信息

Singapore Eye Research Institute, Singapore National Eye Centre, Singapore.

Duke-NUS Medical School, National University of Singapore, Singapore.

出版信息

JAMA. 2020 Dec 15;324(23):2375-2377. doi: 10.1001/jama.2020.22829.

DOI:10.1001/jama.2020.22829
PMID:33320207
Abstract
摘要

相似文献

1
Anti-VEGF Therapy or Vitrectomy Surgery for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy.抗血管内皮生长因子治疗或玻璃体切除术治疗增殖性糖尿病视网膜病变所致玻璃体积血
JAMA. 2020 Dec 15;324(23):2375-2377. doi: 10.1001/jama.2020.22829.
2
Cost Analysis of Intravitreal Aflibercept vs Vitrectomy With Panretinal Photocoagulation for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy.增生型糖尿病视网膜病变玻璃体积血行玻璃体切割联合全视网膜光凝与玻璃体腔内注射阿柏西普的成本分析。
JAMA Ophthalmol. 2021 Jul 1;139(7):804-805. doi: 10.1001/jamaophthalmol.2021.1565.
3
Infographic: intravitreous aflibercept vs vitrectomy with panretinal photocoagulation for vitreous haemorrhage from proliferative diabetic retinopathy.信息图：玻璃体内注射阿柏西普与玻璃体切割联合全视网膜光凝治疗增殖性糖尿病视网膜病变所致玻璃体积血的对比
Eye (Lond). 2022 Jan;36(1):8-9. doi: 10.1038/s41433-021-01530-0. Epub 2021 May 26.
4
[Timing of vitrectomy for proliferative diabetic retinopathy in cases with type II diabetes mellitus].[2型糖尿病患者增殖性糖尿病视网膜病变玻璃体切除术的时机]
Zhonghua Yan Ke Za Zhi. 1999 Mar;35(2):116-8.
5
Early vitrectomy for severe proliferative diabetic retinopathy in eyes with useful vision. Clinical application of results of a randomized trial--Diabetic Retinopathy Vitrectomy Study Report 4. The Diabetic Retinopathy Vitrectomy Study Research Group.
Ophthalmology. 1988 Oct;95(10):1321-34. doi: 10.1016/s0161-6420(88)33014-9.
6
The effect of adjunctive intravitreal conbercept at the end of diabetic vitrectomy for the prevention of post-vitrectomy hemorrhage in patients with severe proliferative diabetic retinopathy: a prospective, randomized pilot study.糖尿病玻璃体切除术后联合应用康柏西普辅助治疗对预防严重增生性糖尿病视网膜病变患者术后出血的效果：一项前瞻性、随机试验研究。
BMC Ophthalmol. 2020 Feb 3;20(1):43. doi: 10.1186/s12886-020-1321-9.
7
PERSISTENT OVERPRODUCTION OF INTRAOCULAR VASCULAR ENDOTHELIAL GROWTH FACTOR AS A CAUSE OF LATE VITREOUS HEMORRHAGE AFTER VITRECTOMY FOR PROLIFERATIVE DIABETIC RETINOPATHY.持续性眼内血管内皮生长因子过度产生作为增殖性糖尿病视网膜病变玻璃体切除术后晚期玻璃体出血的一个原因
Retina. 2017 Dec;37(12):2317-2325. doi: 10.1097/IAE.0000000000001490.
8
[Effectiveness of cryocoagulation and posterior vitrectomy in proliferative diabetic retinopathy complicated by hemorrhage into the vitreous body].[冷冻凝固术与玻璃体后段切除术治疗增殖性糖尿病视网膜病变合并玻璃体积血的疗效]
Oftalmol Zh. 1988(2):76-9.
9
[Management of intra-vitreous hemorrhage in diabetes].
Oftalmologia. 2002;55(4):70-6.
10
Endolaserless Vitrectomy With Aflibercept Monotherapy for Proliferative Diabetic Retinopathy-Related Vitreous Hemorrhage.阿柏西普单药治疗增生性糖尿病视网膜病变相关玻璃体积血的无内激光玻璃体切除术
Ophthalmic Surg Lasers Imaging Retina. 2023 Oct;54(10):609-610. doi: 10.3928/23258160-20230728-02. Epub 2023 Oct 1.

引用本文的文献

1
Vitrectomy Alone Versus Anti-vascular Endothelial Growth Factor (Anti-VEGF) Therapy Prior to Vitrectomy for Diabetic Vitreous Hemorrhage: A Systematic Review and Meta-Analysis.单纯玻璃体切除术与糖尿病性玻璃体积血玻璃体切除术前抗血管内皮生长因子（抗VEGF）治疗的比较：一项系统评价和Meta分析
Cureus. 2025 Aug 11;17(8):e89778. doi: 10.7759/cureus.89778. eCollection 2025 Aug.
2
Comparing scleral wound suturing and non-suturing in 23-gauge vitrectomy combined with cataract phacoemulsification for the management of proliferative diabetic retinopathy.比较23G玻璃体切除术联合白内障超声乳化术治疗增生性糖尿病视网膜病变时巩膜伤口缝合与不缝合的效果。
BMC Ophthalmol. 2025 Apr 18;25(1):226. doi: 10.1186/s12886-025-04068-x.
3
MSCs act as biopatches for blood-retinal barrier preservation to enhance functional recovery after retinal I/R.
间充质干细胞作为生物贴片用于保护血视网膜屏障，以增强视网膜缺血/再灌注后的功能恢复。
Mol Ther Nucleic Acids. 2025 Jan 2;36(1):102445. doi: 10.1016/j.omtn.2024.102445. eCollection 2025 Mar 11.
4
Natural remedies proposed for the management of diabetic retinopathy (DR): diabetic complications.用于治疗糖尿病视网膜病变（DR）的天然疗法：糖尿病并发症。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Feb 15. doi: 10.1007/s00210-025-03866-w.
5
Visual Outcome of Nontraumatic Dense Vitreous Hemorrhage in Patients without Diabetes: A Single-Center Case Series.非糖尿病患者非创伤性致密玻璃体出血的视力预后：一项单中心病例系列研究
Korean J Ophthalmol. 2024 Jun;38(3):179-184. doi: 10.3341/kjo.2023.0116. Epub 2024 Apr 8.
6
Angiogenic and Fibrogenic Dual-effect of Gremlin1 on Proliferative Diabetic Retinopathy.Gremlin1 对增殖性糖尿病视网膜病变的血管生成和纤维化双重作用。
Int J Biol Sci. 2024 Jan 12;20(3):897-915. doi: 10.7150/ijbs.85735. eCollection 2024.
7
Engineered mesenchymal stem cell-derived small extracellular vesicles for diabetic retinopathy therapy through HIF-1α/EZH2/PGC-1α pathway.通过HIF-1α/EZH2/PGC-1α通路工程化间充质干细胞衍生的小细胞外囊泡用于糖尿病视网膜病变治疗
Bioact Mater. 2023 Nov 28;33:444-459. doi: 10.1016/j.bioactmat.2023.11.008. eCollection 2024 Mar.
8
Early versus Late Pars Plana Vitrectomy in Vitreous Hemorrhage: A Systematic Review.玻璃体出血中行早期与晚期玻璃体切除术的系统评价
J Clin Med. 2023 Oct 20;12(20):6652. doi: 10.3390/jcm12206652.
9
Acute non-traumatic visual decline in a patient.一名患者出现急性非创伤性视力下降。
J Am Coll Emerg Physicians Open. 2022 Mar 14;3(2):e12707. doi: 10.1002/emp2.12707. eCollection 2022 Apr.
10
Müller glia-derived exosomal miR-9-3p promotes angiogenesis by restricting sphingosine-1-phosphate receptor S1P in diabetic retinopathy.缪勒胶质细胞衍生的外泌体miR-9-3p通过限制糖尿病视网膜病变中的鞘氨醇-1-磷酸受体S1P促进血管生成。
Mol Ther Nucleic Acids. 2021 Dec 17;27:491-504. doi: 10.1016/j.omtn.2021.12.019. eCollection 2022 Mar 8.